| Trial name or title | A randomised study to evaluate the safety and efficacy of IDX719 in combinations with simeprevir and/or TMC647055/ritonavir with or without ribavirin for 12 weeks in subjects with chronic hepatitis C infection |
| Methods | Randomised clinical trial |
| Participants | Treatment‐naïve, genotype 1b, 4 and 6 hepatitis C virus‐infected participants |
| Interventions | Samatasvir |
| Outcomes | |
| Starting date | 6 May 2013 |
| Contact information | |
| Notes | NCT01852604 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.